Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer
Clinical trial NCT01880385 · UNKNOWN
Trial details
- NCT number
- NCT01880385
- Sponsor
- Association Tunisienne de lutte Contre le Cancer
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2013-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.